Abstract
Flagship Projects (FPs) are defined as multidisciplinary research partnerships, aimed at aligning capabilities to confront big transformative goals in major significant areas of research. Their large-scale, long-term, and clear focus on adaptation and adoption of research outputs and outcomes are designed to maximize delivery of positive impact on the national vision for development. Therefore, an FP serves to generate model solutions to important challenges faced by the society and the country, while generating awareness of the problem among the public leading to national or international visibility. Since the year 2020, COVID-19 pandemic has caused and still is inflicting severe impacts on health, economy, and the environment. Kuwait has acted promptly to limit its spread within its borders. Kuwait Institute for Scientific Research (KISR) forms a key role in the national innovation ecosystem. In addition to establishing policies, health and safety measures, and awareness campaign programs on the pandemic, KISR has established a Task Force in March 2020, to oversee its multidisciplinary FP, tackling the pandemic-related challenges to accelerate the preparation of research proposals in public health, economics, the environment, water security, food security, and other innovative pandemic-related issues in the fields of artificial intelligence (AI), Internet of Things (IoT) and information technology (IT). Funding sources for the FP were provided by Kuwait Foundation for the Advancement of Science (KFAS) and KISR. The outcomes of the FP provided solutions for sustainable recovery and overcoming challenges arising from infectious diseases in the country. It has also accelerated the preparation and execution of the research and development (R&D) projects related to the COVID-19 pandemic in addition to sharing results with local authorities for mitigation measures. Application of FPs at research institutions like KISR is necessary and highly recommended to direct the efficient and productive use of institutional resources in terms of workforce, facility, and finances.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
World Health Organization (2022) WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/
Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, Hasell J, Macdonald B, Beltekian D, Roser M (2020) Coronavirus pandemic (COVID-19). Our world in data. https://ourworldindata.org/coronavirus/country/kuwait
Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Ann Rev Virol 3(1):237–261. https://doi.org/10.1146/annurev-virology-110615-042301
Alsaadi EAJ, Jones IM (2019) Membrane binding proteins of coronaviruses. Futur Virol 14(4):275–286. https://doi.org/10.2217/fvl-2018-0144
Nascimento Junior JAC, Santos AM, Quintans-Júnior LJ, Walker CIB, Borges LP, Serafini MR (2020) SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review. Expert Opin Ther Pat 30(8):567–579. https://doi.org/10.1080/13543776.2020.1772231
Liu Y, Gayle AA, Wilder-Smith A, Rocklov J (2020) The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 27(2):taaa021. https://doi.org/10.1093/jtm/taaa021
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
World Health Organization (2020) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance. https://apps.who.int/iris/handle/10665/331329
de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ (2017) Host factors in coronavirus replication. In: Tripp R, Tompkins S (eds) Roles of host gene and non-coding RNA expression in virus infection. Curr Topics Microbiol Immunol 419. https://doi.org/10.1007/82_2017_25
Global Challenges Foundation (2020) A new understanding of global health security: three interlocking functions. https://globalchallenges.org/wp-content/uploads/2021/12/A-new-understanding-of-global-heath-security-UPDATED.pdf
Al-Tawfig JA, Auwaerter PG (2019) Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. J Hosp Infect 101(1):20–29. https://doi.org/10.1016/j.jhin.2018.05.021
Schmidt C (2020) Genetic engineering could make a COVID-19 vaccine in months rather than years candidates are speeding toward human trials. Scientific American. Medicine. https://www.scientificamerican.com/article/genetic-engineering-could-make-a-covid-19-vaccine-in-months-rather-than-years1/
Dale A (2021) How vaccine industry and biotechs can accelerate pandemic responses. LABIOTECH.eu. https://www.labiotech.eu/partner/vaccine-development-accelerate-pandemic-responses/
Center for Systems Science and Engineering (CSSE). (2022) COVID-19 dashboard. John Hopkins University. https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6
Ewen C (2020) The race for coronavirus vaccines. Nature 580:576–577. https://doi.org/10.1038/d41586-020-01221-y
World Health Organization (2022) Coronavirus disease (COVID-19): vaccines. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines
Editorial, (2020) Coronavirus: three things all governments and their science advisers must do now; Follow World Health Organization advice, end secrecy in decision-making and cooperate globally. Nature 579:319–320. https://doi.org/10.1038/d41586-020-00772-4
Walker PGT et al (2020) The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science 369(6502):413–422. https://doi.org/10.1126/science.abc0035
Bruegel Datasets (2020) The fiscal response to the economic fallout from the coronavirus. https://www.bruegel.org/publications/datasets/covid-national-dataset/.
World Health Organization. Global research on coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov
World Health Organization. R&D blueprint and COVID-19. https://www.who.int/teams/blueprint/covid-19.
Rapid microbiology (2020) Rapid microbiology: coronavirus (SARS-CoV-2): Test kits to detect the causative agent of COVID-19. https://www.rapidmicrobiology.com/test-method/testing-for-the-wuhan-coronavirus-a-k-a-covid-19-sars-cov-2-and-2019-ncov
COVID-19 Clinical Research Coalition (2020) Global coalition to accelerate COVID-19 clinical research in resource-limited settings. Lancet 395(10233):1322–1325. https://doi.org/10.1016/S0140-6736(20)30798-4
Sheridan C (2020) Fast, portable tests come online to curb coronavirus pandemic. Nat Biotechnol 38(5):515–518. https://doi.org/10.1038/d41587-020-00010-2
Mboowa G (2020) Current and emerging diagnostic tests available for the novel COVID-19 global pandemic. AAS Open Research, 3:8. https://doi.org/10.12688/aasopenres.13059.1
Lambert-Niclot S, Cuffel A, Le Pape S, Vauloup-Fellous C, Morand-Joubert L, Roque-Afonso A-M, Le Goff J, Delaugerre C, on behalf of the AP-HP/Universities/INSERM COVID-19 Research Collaboration (2020) Evaluation of a rapid diagnostic assay for detection of SARS-CoV-2 antigen in nasopharyngeal swabs. J Clin Microbiol 58:8.https://doi.org/10.1128/JCM.00977-20
World Health Organization (2020) Laboratory biosafety guidelines related to coronavirus disease 2019 (COVID-19). Interim Guidance. https://apps.who.int/iris/bitstream/handle/10665/331138/WHO-WPE-GIH-2020.1-eng.pdf
Habibi N, Uddin S, Al-Salameen F, Amad S, KumarV, Al-Otaibi M (2021) Identification and characterization of novel corona and associated respiratory viruses in aerosols. KISR, Online resources. https://www.kfas.org/media-publications/research-studies-whitepaper/Identification-and-Characterization-of-Novel-Corona
Alkhamis MA, Al Youha S, Khajah MM, Ben Haider N, Alhardan S, Nabeel A, Al Mazeedi S, Al-Sabah SK (2020) Spatiotemporal dynamics of the COVID-19 pandemic in the State of Kuwait. Int J Infect Dis 98:153–160. https://doi.org/10.1016/j.ijid.2020.06.078
Albader F, Al-Raqom F (2020) The right to online education in Kuwait, Revisited in light of covid-19. ILSA J Int Comp Law 27(1/2):1–25. https://nsuworks.nova.edu/ilsajournal/vol27/iss1/2/
Salman A, Sigodo KO, Al-Ghadban F, Al-Lahou B, Alnashmi M, Hermassi S, Chun S (2021) Effects of COVID-19 lockdown on physical activity and dietary behaviors in Kuwait: a cross-sectional study. Nutrients 13(7). https://doi.org/10.3390/nu13072252
Al-Khalaifah H, Al-Nasser A, Abdulmalek N, Al-Mansour H, Ahmed A, Ragheb G (2020) Impact of SARS-Con-V2 on the poultry industry in Kuwait: a case study. Front Vet Sci 7:656. https://doi.org/10.3389/fvets.2020.577178
Acknowledgements
The authors express their appreciation to the Kuwait Foundation for the Advancement of Science (KFAS) for providing funds to support the execution of projects at Kuwait Institute for Scientific Research (KISR). Thanks are also extended to the Executive Directors (Eds) and Project Leaders (PLs) of KISR for providing information on their projects. Thanks, are also due to the FOC and TF for reviewing and evaluating the project ideas.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Asem, S.O., AlMomin, S. (2022). Flagship Projects for Accelerating R&D During the COVID-19 Period in Kuwait. In: Badran, A., Baydoun, E., Mesmar, J. (eds) Higher Education in the Arab World. Springer, Cham. https://doi.org/10.1007/978-3-031-07539-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-031-07539-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-07538-4
Online ISBN: 978-3-031-07539-1
eBook Packages: EducationEducation (R0)